NCT00374309View on ClinicalTrials.gov

Experimental Vaccine for Prevention of Ebola Virus Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 5, 2006

Study Completion Date

May 5, 2009

Conditions
Ebola Hemorrhagic FeverEbola Virus DiseaseEbola Virus VaccinesEnvelope Glycoprotein, Ebola VirusFilovirus
Interventions
DRUG

VRC-EBOADV018-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00374309 - Experimental Vaccine for Prevention of Ebola Virus Infection | Biotech Hunter | Biotech Hunter